BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8547829)

  • 1. Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation.
    Mooney LA; Santella RM; Covey L; Jeffrey AM; Bigbee W; Randall MC; Cooper TB; Ottman R; Tsai WY; Wazneh L
    Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):627-34. PubMed ID: 8547829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers.
    Sarkar M; Stabbert R; Kinser RD; Oey J; Rustemeier K; von Holt K; Schepers G; Walk RA; Roethig HJ
    Toxicol Appl Pharmacol; 2006 Jun; 213(3):198-206. PubMed ID: 16405939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA adducts, protein adducts, and sister chromatid exchange in cigarette smokers and nonsmokers.
    Perera FP; Santella RM; Brenner D; Poirier MC; Munshi AA; Fischman HK; Van Ryzin J
    J Natl Cancer Inst; 1987 Sep; 79(3):449-56. PubMed ID: 3114532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycophorin A somatic cell mutation frequencies in Finnish reinforced plastics workers exposed to styrene.
    Bigbee WL; Grant SG; Langlois RG; Jensen RH; Anttila A; Pfäffli P; Pekari K; Norppa H
    Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):801-10. PubMed ID: 8896891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline of the hemoglobin adduct of 4-aminobiphenyl during withdrawal from smoking.
    Maclure M; Bryant MS; Skipper PL; Tannenbaum SR
    Cancer Res; 1990 Jan; 50(1):181-4. PubMed ID: 2293553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of DNA adducts and sister chromatid exchange in lung cancer cases and controls.
    Perera F; Mayer J; Jaretzki A; Hearne S; Brenner D; Young TL; Fischman HK; Grimes M; Grantham S; Tang MX
    Cancer Res; 1989 Aug; 49(16):4446-51. PubMed ID: 2743334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoperoxidase quantitation of 4-aminobiphenyl- and polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers.
    Hsu TM; Zhang YJ; Santella RM
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):193-9. PubMed ID: 9138663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
    Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary tobacco-specific nitrosamines and 4-aminobiphenyl hemoglobin adducts measured in smokers of either regular or light cigarettes.
    Bernert JT; Jain RB; Pirkle JL; Wang L; Miller BB; Sampson EJ
    Nicotine Tob Res; 2005 Oct; 7(5):729-38. PubMed ID: 16191744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of benzo[a]pyrene-DNA adducts from leukocytes from heavy smokers.
    Arnould JP; Hermant A; Levi-Valensi P; Belegaud J
    Pathol Biol (Paris); 1998 Dec; 46(10):787-90. PubMed ID: 9922995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition prospective study.
    Airoldi L; Vineis P; Colombi A; Olgiati L; Dell'Osta C; Fanelli R; Manzi L; Veglia F; Autrup H; Dunning A; Garte S; Hainaut P; Hoek G; Krzyzanowski M; Malaveille C; Matullo G; Overvad K; Tjonneland A; Clavel-Chapelon F; Linseisen J; Boeing H; Trichopoulou A; Palli D; Peluso M; Krogh V; Tumino R; Panico S; Bueno-De-Mesquita HB; Peeters PH; Lund E; Agudo A; Martinez C; Dorronsoro M; Barricarte A; Chirlaque MD; Quiros JR; Berglund G; Järvholm B; Hallmans G; Day NE; Allen N; Saracci R; Kaaks R; Riboli E
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2118-24. PubMed ID: 16172219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral administration of N-acetyl-L-cysteine: a multi-biomarker study in smokers.
    Van Schooten FJ; Besaratinia A; De Flora S; D'Agostini F; Izzotti A; Camoirano A; Balm AJ; Dallinga JW; Bast A; Haenen GR; Van't Veer L; Baas P; Sakai H; Van Zandwijk N
    Cancer Epidemiol Biomarkers Prev; 2002 Feb; 11(2):167-75. PubMed ID: 11867504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Hydroxy-1-(3-pyridyl)-1-butanone-releasing DNA adducts in lung, lower esophagus and cardia of sudden death victims.
    Schlöbe D; Hölzle D; Hatz D; von Meyer L; Tricker AR; Richter E
    Toxicology; 2008 Mar; 245(1-2):154-61. PubMed ID: 18243467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
    Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B
    Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dramatic decline in circulating intercellular adhesion molecule-1 concentration on quitting tobacco smoking.
    Scott DA; Stapleton JA; Wilson RF; Sutherland G; Palmer RM; Coward PY; Gustavsson G
    Blood Cells Mol Dis; 2000 Jun; 26(3):255-8. PubMed ID: 10950946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
    Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers.
    Bryant MS; Skipper PL; Tannenbaum SR; Maclure M
    Cancer Res; 1987 Jan; 47(2):602-8. PubMed ID: 3791245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index modulates aromatic DNA adduct levels and their persistence in smokers.
    Godschalk RW; Feldker DE; Borm PJ; Wouters EF; van Schooten FJ
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):790-3. PubMed ID: 12163336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applicability of induced sputum for molecular dosimetry of exposure to inhalatory carcinogens: 32P-postlabeling of lipophilic DNA adducts in smokers and nonsmokers.
    Besaratinia A; Maas LM; Van Breda SG; Curfs DM; Kleinjans JC; Wouters EF; Van Schooten FJ
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):367-72. PubMed ID: 10794480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of N-(2-hydroxyethyl)valine due to exposure to ethylene oxide via tobacco smoke: A risk factor for onset of cancer.
    Bono R; Vincenti M; Meineri V; Pignata C; Saglia U; Giachino O; Scursatone E
    Environ Res; 1999 Jul; 81(1):62-71. PubMed ID: 10361027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.